Cargando…

Managing hyponatremia in lung cancer: latest evidence and clinical implications

Hyponatremia is the most common electrolyte disorder in lung cancer patients. This condition may be related to many causes including incidental medications, concurrent diseases and side effects of antineoplastic treatments or the disease itself. Although not frequently life-threatening, it is usuall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiordoliva, Ilaria, Meletani, Tania, Baleani, Maria Giuditta, Rinaldi, Silvia, Savini, Agnese, Di Pietro Paolo, Marzia, Berardi, Rossana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764155/ https://www.ncbi.nlm.nih.gov/pubmed/29344107 http://dx.doi.org/10.1177/1758834017736210

Ejemplares similares

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
por: Berardi, Rossana, et al.
Publicado: (2020)

Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study
por: Fucà, Giovanni, et al.
Publicado: (2019)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
por: Giampieri, Riccardo, et al.
Publicado: (2020)

An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2021)

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis
por: Giampieri, Riccardo, et al.
Publicado: (2017)

Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer
por: Bittoni, Alessandro, et al.
Publicado: (2021)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
por: Moroncini, Gianluca, et al.
Publicado: (2018)

Optimal management of resected gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2018)

Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis
por: Lenci, Edoardo, et al.
Publicado: (2021)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2017)

Targeted therapy of brain metastases: latest evidence and clinical implications
por: Di Lorenzo, Rodica, et al.
Publicado: (2017)

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
por: Santoni, Matteo, et al.
Publicado: (2018)

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
por: Personeni, Nicola, et al.
Publicado: (2018)

Implications of Hyponatremia in Liver Transplantation
por: Cimen, Sertac, et al.
Publicado: (2014)

Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy
por: Giampieri, Riccardo, et al.
Publicado: (2023)

Treatment of diverticular disease: an update on latest evidence and clinical implications
por: Carabotti, Marilia, et al.
Publicado: (2018)

Adding ezetimibe to statin therapy: latest evidence and clinical implications
por: Vavlukis, Marija, et al.
Publicado: (2018)

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
por: Murrone, Albero, et al.
Publicado: (2021)

Latest SARS evidence
por: Walgate, Robert
Publicado: (2003)

Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications
por: Terada, Naoki, et al.
Publicado: (2017)

Adaptation of the Brain to Hyponatremia and Its Clinical Implications
por: Gankam Kengne, Fabrice
Publicado: (2023)

Latest evidence on immunotherapy for cholangiocarcinoma
por: Guo, Xurui, et al.
Publicado: (2020)

Evidence-based hyponatremia management in liver disease
por: Ryu, Ji Young, et al.
Publicado: (2023)

Cow's milk proteins allergy: the latest on therapy
por: Duse, Marzia, et al.
Publicado: (2015)

Leave pooling—the latest trend: Implications
por: Upadhyaya, Suneet Kumar, et al.
Publicado: (2011)

Hyponatremia after aneurysmal subarachnoid hemorrhage: Implications and outcomes
por: Saramma, PP, et al.
Publicado: (2013)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Effect of Optimal Thyroid Replacement Therapy on Chronic Hyponatremia with Focused Review of the Evidence, Mechanisms, and Clinical Implications
por: Chaudhary, Nadia, et al.
Publicado: (2019)

Latest Evidence on Sulfonylureas: What’s New?
por: Leiter, Lawrence A.
Publicado: (2020)

Ghrelin Enhancer, the Latest Evidence of Rikkunshito
por: Yamada, Chihiro, et al.
Publicado: (2021)

The Latest Evidence of Erythropoietin in the Treatment of Glaucoma
por: Lin, Ting-Yi, et al.
Publicado: (2022)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Conivaptan: Evidence supporting its therapeutic use in hyponatremia
por: Li-Ng, Melissa, et al.
Publicado: (2010)

Are liver nested stromal epithelial tumors always low aggressive?
por: Meletani, Tania, et al.
Publicado: (2017)

Glucocorticoids and Water Balance: Implications for Hyponatremia Management and Pituitary Surgery
por: Castle-Kirszbaum, Mendel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5c9vsjjfa3k31cg0p50kv8ql40